Vietnam Investment Review on MSN
BiPASS Prostate Cancer Study Begins Patient Dosing
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient in the United States (U.S.) ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
More than 370,000 insured patients in the US underwent kidney stone surgery in 2019, highlighting the importance of the 2026 AUA guidelines.
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix) provides an update on its commercial and operational performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results